News Pfizer looks to M&A after results disappointment Pfizer is looking to deals to keep investors onside after a disappointing set of Q4 results.
News Don't cut prices, cut taxes, pharma CEO tells Trump Industry plays key role in job creation too, says Novartis CEO.
News Pfizer, Novo invest in Swedish patient stratification startu... Funds will go towards development of AMRA's body composition profiling tool AMRA Profiler.
News Pharma project aims to help doctors find drug info Industry giants such as AstraZeneca and Novartis are on board.
News Growth hormone could be filed without further trials, says O... Drug could be filed after "outlier" analysis.
News AZ, Avillion's Airsupra aces asthma rescue therapy trial A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.